DAKT shows massive revenue growth of 377% but swung to a $10.1M loss despite maintaining strong cash generation, indicating serious profitability challenges amid rapid expansion.
The dramatic revenue surge paired with a swing from $34.6M profit to $10.1M loss suggests the company may be sacrificing margins for growth or facing significant operational inefficiencies as it scales. The 62% drop in operating income despite nearly 5x revenue growth is particularly concerning and warrants close scrutiny of management's execution strategy.
DAKT delivered exceptional 377% revenue growth to $608.9M but profitability collapsed with net income swinging from $34.6M profit to $10.1M loss, while operating income plummeted 62% despite the revenue surge. The company maintained strong liquidity with cash rising 57% to $127.5M and operating cash flow increasing 55% to $97.7M, while working capital improved through inventory and receivables reductions. This financial profile suggests a company experiencing rapid growth but struggling with operational leverage and margin management during its expansion phase.
Strong top-line growth of 377% — accelerating demand or successful expansion into new markets.
Net income declined 129.2% — review whether driven by operations, interest costs, or non-recurring items.
Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.
Cash position surged 56.8% — strong cash generation or capital raise providing significant financial cushion.
Operating cash flow surged 54.5% — exceptional cash generation, highest quality earnings signal.
Inventory reduced 23.3% — lean inventory management or demand outpacing supply.
Receivables declined — improved collection efficiency or conservative revenue recognition.
Equity base grew 13.9% — retained earnings accumulation or equity issuance strengthening the balance sheet.
Gross margin compression — rising input costs, pricing pressure, or unfavorable product mix shift.
Current liabilities reduced — improved short-term financial position and working capital health.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →